AU7119187A - Ester prodrugs of dopamine-beta-hydroxylase inhibitors - Google Patents
Ester prodrugs of dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- AU7119187A AU7119187A AU71191/87A AU7119187A AU7119187A AU 7119187 A AU7119187 A AU 7119187A AU 71191/87 A AU71191/87 A AU 71191/87A AU 7119187 A AU7119187 A AU 7119187A AU 7119187 A AU7119187 A AU 7119187A
- Authority
- AU
- Australia
- Prior art keywords
- dopamine
- beta
- ester prodrugs
- hydroxylase inhibitors
- hydroxylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/849,333 US4743613A (en) | 1986-04-08 | 1986-04-08 | Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity |
US849333 | 1986-04-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7119187A true AU7119187A (en) | 1987-10-15 |
AU600480B2 AU600480B2 (en) | 1990-08-16 |
Family
ID=25305580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU71191/87A Ceased AU600480B2 (en) | 1986-04-08 | 1987-04-08 | Ester prodrugs of dopamine-beta-hydroxylase inhibitors |
Country Status (7)
Country | Link |
---|---|
US (1) | US4743613A (en) |
EP (1) | EP0244956A1 (en) |
JP (1) | JPS62242669A (en) |
AU (1) | AU600480B2 (en) |
DK (1) | DK175287A (en) |
PT (1) | PT84624B (en) |
ZA (1) | ZA872482B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU615572B2 (en) * | 1988-09-14 | 1991-10-03 | Du Pont Merck Pharmaceutical Company, The | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4762850A (en) * | 1987-03-24 | 1988-08-09 | Smithkline Beckman Corporation | Dopamine-beta-hydroxylase inhibitors |
US4835154A (en) * | 1987-06-01 | 1989-05-30 | Smithkline Beckman Corporation | 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors |
US4882348A (en) * | 1987-12-29 | 1989-11-21 | Smithkline Beckman Corporation | 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors |
CA2002245A1 (en) * | 1988-12-01 | 1990-06-01 | Lawrence I. Kruse | Dopamine-.beta.-hydroxylase inhibitors |
SK279264B6 (en) * | 1989-05-05 | 1998-08-05 | Rhone-Poulenc Agrochimie | 1-arylimidazoles, method of preparation thereof, use and agent containing 1-arylimidazoles |
US5393913A (en) * | 1993-03-03 | 1995-02-28 | Rhone-Poulenc Inc. | N-formylanilines |
ES2899730T3 (en) | 2012-03-07 | 2022-03-14 | Mclean Hospital Corp | Aminoquinoline derivatives and their uses |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1695093A1 (en) * | 1965-10-21 | 1970-12-10 | Geigy Ag J R | New imidazole derivatives |
DE2259627A1 (en) * | 1972-12-06 | 1974-06-12 | Hoechst Ag | IMIDAZOLYL- (2) -THIO-ALKANEIC ACID ESTERS AND THE PROCESS FOR THEIR PRODUCTION |
DE2609645A1 (en) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | AMINOALKYLHETEROCYCLES |
US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
US4340738A (en) * | 1979-06-21 | 1982-07-20 | Janssen Pharmaceutica, N.V. | 2,3-Dihydro-imidazo[2,1-b]benzothiazoles |
GB2096987B (en) * | 1981-04-22 | 1984-04-04 | Farmos Oy | Substituted imidazole and imidazole derivatives and their preparation and use |
US4487761A (en) * | 1982-04-05 | 1984-12-11 | Merck & Co., Inc. | Dopamine β-hydroxylase inhibitors |
US4532331A (en) * | 1983-04-12 | 1985-07-30 | Smithkline Beckman Corporation | 1-Benzyl-2-aminomethyl imidazole derivatives |
PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
GB2141705B (en) * | 1983-06-20 | 1986-09-24 | Erba Farmitalia | Imidazoles |
US4719223A (en) * | 1985-10-31 | 1988-01-12 | Smithkline Beckman Corporation | Imidazolethiol dopamine-beta-hydroxylase inhibitors |
-
1986
- 1986-04-08 US US06/849,333 patent/US4743613A/en not_active Expired - Fee Related
-
1987
- 1987-04-06 PT PT84624A patent/PT84624B/en not_active IP Right Cessation
- 1987-04-06 DK DK175287A patent/DK175287A/en not_active Application Discontinuation
- 1987-04-06 EP EP87302997A patent/EP0244956A1/en not_active Withdrawn
- 1987-04-07 ZA ZA872482A patent/ZA872482B/en unknown
- 1987-04-07 JP JP62086715A patent/JPS62242669A/en active Pending
- 1987-04-08 AU AU71191/87A patent/AU600480B2/en not_active Ceased
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU615572B2 (en) * | 1988-09-14 | 1991-10-03 | Du Pont Merck Pharmaceutical Company, The | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles |
Also Published As
Publication number | Publication date |
---|---|
PT84624A (en) | 1987-05-01 |
EP0244956A1 (en) | 1987-11-11 |
US4743613A (en) | 1988-05-10 |
JPS62242669A (en) | 1987-10-23 |
DK175287A (en) | 1987-10-09 |
PT84624B (en) | 1989-11-30 |
DK175287D0 (en) | 1987-04-06 |
AU600480B2 (en) | 1990-08-16 |
ZA872482B (en) | 1988-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU546872B2 (en) | Skin treatment compositions containing a fatty acid or ester | |
AU651804B2 (en) | New esters of alginic acid | |
AU7960087A (en) | Cross-linked ester of hyaluronic acid | |
AU583963B2 (en) | Phosphoric ester compound | |
AU1875988A (en) | 5-aralkyl-2-mercaptoimidazole derivatives as dopamine-beta- hydroxylase inhibitors | |
AU8307882A (en) | C10-22 alkyl ester of tyrosine | |
AU1644788A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU3867585A (en) | Esters of p-dimethylamino-cinnamic acid | |
AU6201386A (en) | Preparation of esters | |
AU7119187A (en) | Ester prodrugs of dopamine-beta-hydroxylase inhibitors | |
AU6032886A (en) | Guanidinobenzoyl esters | |
AU580855B2 (en) | Alkeneamidocephalosporin esters | |
AU6463986A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU1258988A (en) | Esters of oxalofluoride | |
AU2936889A (en) | 2-aminoalkylthioimidazoles as dopamine-beta-hydroxylase inhibitors | |
AU8135782A (en) | Phosphoric nphosphonic acid ester amides | |
AU1003188A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU1370688A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU2911389A (en) | 1-aralkyl-2-mercaptoimidazolines as dopamine-beta-hydroxylase inhibitors | |
AU6321086A (en) | Esters of dihydrolysergic acid | |
AU8694291A (en) | Ester inhibitors | |
AU2591984A (en) | Ester of tricyclohexyl-tin hydroxide | |
AU6463886A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU4553889A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU589053B2 (en) | Preparation process of alpha-l-aspartyl-l-phenyl-alanine methyl ester having low hygroscopicity |